Keywords: b-ms, orencia, almost, doubles, ra, remission, usa

B-MS' Orencia almost doubles RA remission

Article | 03 November 2008

Print This

The USA's Bristol-Myers Squibb presented strong results from a Phase IIIb study of its Orencia (abatacept) in the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in